3.4. The Experimental Percentage of TOC Removal Using Chitosan in Different Acidic Solutions
To prepare stock chitosan solutions (1000 mg/L), four acid solutions were formulated using acetic, lactic, and l-ascorbic acids. Depending on their physical state and purity, each acid was either weighed or measured by volume to achieve a target pH range of approximately 3.5–4.5. The acid was first dissolved in 900 mL of deionized water and stirred for 30 min using a magnetic stirrer. Approximately 1 g of chitosan was then added to each solution. The final volume was adjusted to 1000 mL in a volumetric flask and the solutions were shaken using a magnetic stirrer for 20 h. As shown in
Table 4, the pH values of all solutions reached an average of approximately 3.70, which was within the optimal range for effective chitosan solubilization.
3.4.1. Collection and Preparation of Samples for Jar Test
Raw water samples were collected from the Río Grande de Añasco at the intake point of the municipal water treatment plant (MWTP) and transferred into 1000 mL jars. A blank jar was prepared using untreated raw water at three turbidity levels (403, 1220, and 5038 NTU) and monitored over a period of 193 min. This duration was selected to simulate the contact and sedimentation time used in the jar tests with coagulant addition (chitosan in different acidic solutions and aluminum chlorohydrate as the conventional comparator). The temporal evolution of UV254, TOC, and DOC in the blank jars is presented in
Figure 6a, b, and c, respectively.
As expected, the results indicate only minimal variation in all three parameters over the 193 min period, confirming that the observed removals in treated samples are attributable to the action of the coagulants rather than to natural settling or degradation processes occurring in the raw water.
Raw water samples were collected from the Río Grande de Añasco at the intake point of the municipal water treatment plant (MWTP) and transferred into 1000 mL jars. Chitosan solutions, prepared in different acidic media, and sodium hypochlorite (NaOCl) were added at varying doses according to the turbidity level of each sample, as shown in
Table 5.
Multiple jar tests were performed using each chitosan solution prepared in acid to evaluate turbidity removal performance. The dosage that resulted in the lowest turbidity was identified from each set of jar tests. Based on these preliminary results, a final jar test was conducted using doses close to the optimal value previously found. The dose that achieved the lowest turbidity in this final round was selected for comparative analysis of the total organic carbon (TOC) and TOC removal efficiency.
To provide a visual reference for the treatment sequence,
Figure 7 presents the key stages of the jar test process applied to raw river water. These images illustrate the initial appearance of untreated water (a), rapid mixing during the coagulation phase (b), slow mixing during flocculation (c), and the sedimentation phase (d). This sequence reflects the standard coagulation–flocculation protocol applied throughout the study and helps contextualize the subsequent turbidity and TOC removal results.
To assess the performance of the flocculation product, turbidity readings were taken at the inlet (NTU RW) and outlet (NTU out) of the flocculation unit at 32 min intervals (MWTP flocculation process), corresponding to the typical duration (30 min) of a complete flocculation cycle, as described by Letterman [
5]. These measurements were used to calculate flocculation efficiency under varying raw water conditions. The efficiency of the flocculation process (EFP) was calculated using Equation (4). The graphical results revealed that among the tested doses, one specific dose of acetic acid consistently achieved both the lowest TOC concentration and the lowest turbidity level at the end of the treatment period. This outcome indicates that the selected dose was effective not only in removing dissolved organic matter but also in reducing particulate matter, making it the most efficient. These combined results are critical for identifying the optimal coagulant dose because both TOC and turbidity are key indicators of water quality. Accordingly, this dose was selected as the optimal dose and used as the reference condition in the comparative analysis of TOC removal efficiencies among the different acids. Selecting the dose that delivers the best combined performance ensures consistency and reliability when evaluating the effectiveness of coagulants across treatments. The jar test procedure was designed to replicate the actual coagulation–flocculation conditions applied at a municipal water treatment plant (MWTP). The tests followed a structured mixing protocol, as detailed in the Materials and Methods section.
3.4.2. Chitosan in Acetic Acid Solution at Different Raw Water Turbidity Ranges
For raw water with an initial turbidity of 403 NTU,
Table 6 presents the first stage of jar testing using chitosan dissolved in acetic acid, with a concentration range from 0.50 to 20.0 mg/L (Jar 5 representing the optimal dose). The second stage of the test, analyzed at 32 min of processing, is also shown in
Table 6, with Jar 3 corresponding to the optimal concentration at that point.
The optimal dose was 8.00 mg/L, which resulted in a final turbidity of 6.40 NTU at 193 min, corresponding to Jar 3. As described previously, EFP was calculated using the inlet and outlet turbidity values to assess flocculation performance in this turbidity range. In this case, the raw water turbidity was 403 NTU and the outlet turbidity after flocculation with the selected dose was 9.18 NTU, resulting in an EFP of 97.7%. These findings indicate that chitosan effectively promoted the formation of dense and well-structured flocs by the end of the flocculation process, contributing to the high removal efficiency observed, and confirming the effectiveness of the selected dose under these raw water conditions.
The TOC concentration corresponding to Jar 3, with 8.00 mg/L of chitosan in acetic acid, was 2.76, 1.99, 1.99 to 32, 178, and 193 min, respectively, and the DOC concentration was 1.72 mg/L at 193 min. These results indicate a significant reduction in organic carbon content as flocculation progressed, suggesting that chitosan promoted the formation of dense, settleable flocs with a high binding capacity for organic matter.
For raw water with an initial turbidity of 1220 NTU, the first stage of jar testing using chitosan in acetic acid (concentration range: 3.00 to 30.0 mg/L) is presented in
Table 7, with Jar 3 corresponding to the optimal concentration. The second stage focused on a refined dose range (8.00 to 14.0 mg/L) to determine the precise optimal dosage.
Table 7 also includes the results from this second stage, with turbidity measurements taken at 32 min of processing. The optimal dose was found to be 10.0 mg/L, which achieved a turbidity of 12.7 NTU at 32 min and a final turbidity of 6.20 NTU at 193 min, corresponding to Jar 3.
As described previously, EFP was calculated using the inlet and outlet turbidity values to assess flocculation performance in this turbidity range. In this case, the raw water turbidity was 1220 NTU, and the outlet turbidity after flocculation with the selected dose was 12.7 NTU, resulting in an EFP of 99.0%. These results demonstrate a high level of removal by the end of the flocculation process, indicating that chitosan exhibited strong performance in floc formation and floc weight development, and confirmed the effectiveness of the selected dose under these raw water conditions.
The TOC concentration corresponding to Jar 3, with 10.0 mg/L of chitosan in acetic acid was 2.01, 2.02, and 1.98 at 32, 178, and 193 min, respectively, and the DOC concentration was 1.16 mg/L at 193 min. These results indicate a significant reduction in organic carbon content as flocculation progressed, suggesting that chitosan promoted the formation of dense, settleable flocs with a high binding capacity for organic matter.
For raw water with an initial turbidity of 5038 NTU, the first stage of jar testing evaluated a broad dose range (10.0–50.0 mg/L) to identify the optimal concentration.
Table 8 presents the results from this first stage, with turbidity measurements taken at 32 min of processing. The second stage focused on a narrower dose range (16.0–23.0 mg/L) to refine the optimal dosage.
Table 8 also includes the results from this second stage, with turbidity again analyzed at 32 min. The optimal dose was determined to be 17.0 mg/L, which resulted in a turbidity of 12.7 NTU at 32 min and a final turbidity of 4.68 NTU at 193 min, corresponding to Jar 2.
As described previously, EFP was calculated using the inlet and outlet turbidity values to assess flocculation performance in this turbidity range. In this case, the raw water turbidity was 5038 NTU and the outlet turbidity after flocculation with the selected dose was 12.2 NTU, resulting in an EFP of 99.8%. The observed removal efficiency at the end of the flocculation process suggests that chitosan was highly effective in promoting the aggregation and settling of suspended solids, leading to the formation of stable, high-density flocs, and confirming the effectiveness of the selected dose under these raw water conditions.
The TOC concentration corresponding to Jar 2, with 17.00 mg/L of chitosan in acetic acid was 2.50, 2.25, and 2.24 at 32, 178, and 193 min, respectively, and the DOC concentration was 1.27 mg/L at 193 min. These results indicate a significant reduction in organic carbon content as flocculation progressed, suggesting that chitosan promoted the formation of dense, settleable flocs with a high binding capacity for organic matter.
The experimental percentage of TOC removal (% TOC removal exp) was calculated from the data obtained using Equation (5) and compared with the theoretical value estimated using Equation (2). As shown in
Table 9, the TOC removal performance and flocculation efficiency were evaluated at different turbidity ranges using acetic acid. The results demonstrated that the efficiency of the coagulation–flocculation process varied with turbidity levels, with higher turbidity samples generally requiring higher doses of acetic acid and achieving greater TOC removal. This table presents the experimental TOC removal percentages and flocculation efficiencies at specific time points for each turbidity level. The coagulation–flocculation test results showed TOC removal that was consistent with the requirements set by the EPA and predictions based on the SUVA values. For samples with an alkalinity of 80 mg/L, the EPA required a 25% removal of TOC levels between 2 and 4 mg/L, and 35% removal for TOC levels above 4 mg/L. For the sample with 403 NTU (initial TOC of 3.67 mg/L), 35.2% removal was achieved, exceeding the minimum requirement of 25%. The sample with 1220 NTU (initial TOC of 4.85 mg/L) showed 59.0% removal, surpassing the required removal of 35%. For the sample with 5038 NTU (initial TOC of 8.00 mg/L), the removal reached 72.0%, which is well above the minimum requirement.
Regarding the predictions based on SUVA values, for the samples with turbidity of 403 NTU and 1220 NTU, the expected TOC removal was in the 40–60% range, whereas for the 5038 NTU sample, the prediction was 60–80%. The experimental results were 35.2%, 59.2%, and 72.0%, respectively, and were aligned with expectations based on the SUVA values.
Additionally, flocculation efficiency was high across all samples, with values of 97.7% for the 403 NTU sample, 99.0% for the 1220 NTU sample, and 99.8% for the 5038 NTU sample, indicating effective removal of suspended particles, and contributing to significant reductions in turbidity and TOC.
As shown in
Table 9, the TOC removal performance and flocculation process efficiency were evaluated at different turbidity ranges using acetic acid, and the percentage removal of UV
254 absorbance and DOC was calculated using the same formula described in Equation (5), based on the values measured at 193 min. These complementary parameters help to further characterize the nature and extent of organic matter removal. Specifically, for the 403 NTU sample, a 40.9% reduction in UV
254 absorbance and 44.0% DOC removal was achieved. The reduction in UV
254 indicates a decrease in the concentration of aromatic organic compounds, which are typically associated with humic substances and known precursors of disinfection byproducts (DBPs). DOC removal confirmed that a substantial portion of the dissolved organic matter was successfully removed through coagulation–flocculation.
For the 1220 NTU sample, 61.8% UV254 removal and 69.2% DOC removal were observed, indicating a higher removal efficiency, which is consistent with the increased initial organic load and dose applied. In the 5038 NTU sample, which had the highest turbidity levels tested, the UV254 and DOC removal rates were 76.2% and 78.5%, respectively. These high removal rates reflect the predominance of humic high-molecular-weight organic compounds in this sample, which are more amenable to removal via enhanced coagulation. Overall, these findings suggest that the application of chitosan in acetic acid was particularly effective in targeting both aromatic and hydrophilic fractions of natural organic matter (NOM), with higher turbidity waters yielding greater removal efficiencies.
The THM formation potentials (THMFP) before and after treatment are summarized in
Table 3 and
Table 9. A clear reduction in THMFP was observed across all turbidity levels, demonstrating the effectiveness of the coagulation–flocculation process using chitosan in acetic acid in minimizing the precursors associated with disinfection byproduct (DBP) formation.
For the 403 NTU sample, the THMFP in the raw water was 222 µg/L, which decreased to 103 µg/L after the treatment, a reduction of approximately 53.6%. Similarly, the 1220 NTU sample decreased from 314 µg/L to 120 µg/L (61.8% reduction), and the sample with the highest turbidity (5038 NTU) decreased from 587 µg/L to 177 µg/L (69.8% reduction). These substantial reductions in THMFP correlated with the removal of both TOC and DOC, which are key precursors in DBP formation.
The treatment achieved TOC removals of 35.2, 59.2, and 72.0% for the 403, 1220, and 5038 NTU samples, respectively. Likewise, DOC concentrations were significantly reduced, particularly in the high-turbidity samples, where humic and hydrophobic substances dominated and were more readily removed through enhanced coagulation.
The consistent presence of residual chlorine in the finished water (ranging from 0.52 to 0.57 mg/L) confirms that sufficient disinfectant was available to react with any remaining organic matter, yet the THMFP remained substantially lower than in the raw water. This suggests that the reduction in DBP precursors was the main factor driving the observed decrease in THMFP, rather than the variation in chlorine dosage.
Figure 8 presents the comparative results of UV
254 absorbance, total organic carbon (TOC), and dissolved organic carbon (DOC) measured at 193 min for all turbidity levels evaluated in the jar test process. Overall, the treatment not only met but exceeded the U.S. EPA requirements for TOC removal, effectively reducing the potential for trihalomethane (THM) formation in the treated water. These findings highlight the effectiveness and sustainability of chitosan in acetic acid as a viable alternative coagulant for improving drinking water quality.
3.4.3. Chitosan in Lactic Acid Solution at Different Raw Water Turbidity Ranges
For the test performed with raw water at 403 NTU, the first stage of jar test testing is presented in
Table 10, using chitosan in lactic acid with a concentration range of 0.50 to 20.0 mg/L. The second stage of jar testing focused on the dose range of 3.00 to 12.0 mg/L to determine the optimal dosage.
Table 10 shows the jar test at the second stage with the turbidity analyzed at 32 min of process.
The best performance was observed at 8.00 mg/L, which corresponded to Jar 3, reaching a final turbidity of 12.0 NTU after 193 min. To determine the treatment efficiency, flocculation performance (EFP) was computed using turbidity reduction. Given an initial turbidity of 403 NTU and a value of 21.8 NTU after flocculation, the resulting EFP was 94.6%, which confirmed that this dose was highly effective under these conditions.
The TOC values recorded for Jar 3 (8.00 mg/L chitosan in lactic acid) at 32, 178, and 193 min were [2.30, 2.25, 2.25] mg/L, while the DOC concentration at 193 min was 1.50 mg/L. These results indicate a significant reduction in organic carbon content as flocculation progressed, suggesting that chitosan promoted the formation of dense, settleable flocs with a high binding capacity for organic matter.
For raw water exhibiting an initial turbidity of 1220 NTU, the first stage of jar testing with chitosan dissolved in lactic acid is presented in
Table 11, using a concentration range of 3.00 to 30.0 mg/L. The second stage focused on a narrower dose range (8.00–14.0 mg/L) to determine the optimal concentration.
Table 11 also includes the results from this second stage, with turbidity measurements taken at 32 min of processing.
The dose of 12.00 mg/L (Jar 4) was identified as the most efficient, producing a final turbidity of 9.96 NTU at 193 min. The flocculation efficiency (EFP) was assessed based on the decrease in turbidity from the raw water to the post-flocculation stage. With an initial turbidity of 1220 NTU and a value of 22.0 NTU after flocculation, the EFP reached 98.2%, confirming the high effectiveness of this dosage.
The TOC and DOC measurements for Jar 4 (12.00 mg/L) showed consistent reductions over time. These results indicate a significant reduction in organic carbon content as flocculation progressed, suggesting that chitosan promoted the formation of dense, settleable flocs with a high binding capacity for organic matter. Total organic carbon concentrations at 32, 178, and 193 min were [2.19, 2.18, 2.12] mg/L, while the dissolved organic carbon value at 193 min was 1.92 mg/L, indicating that the chitosan in lactic acid combination performed well in removing both dissolved and particulate organic fractions via floc formation.
For highly turbid water with an initial turbidity of 5038 NTU, the first stage of jar testing focused on a dose range of 10.0 to 50.0 mg/L to determine the optimal concentration.
Table 12 presents the results from this first stage, with turbidity measured at 32 min of processing. The second stage involved testing chitosan dissolved in lactic acid across a narrower dose range (16.0 to 23.0 mg/L) to refine the determination of the most effective treatment dosage.
Table 12 also includes the results from this second stage, with turbidity again analyzed at 32 min.
The optimal performance was observed at a dose of 21.00 mg/L (Jar 4), which yielded a final turbidity of 3.14 NTU at 193 min. To assess process performance, flocculation efficiency (EFP) was calculated using the initial and post-treatment turbidity values. In this case, turbidity was reduced from 5038 NTU to 8.84 NTU, resulting in an EFP of 99.8%, confirming excellent removal capacity even under severe turbidity conditions.
TOC concentrations for Jar 4 were [2.86, 2.82, 2.72] mg/L at 32, 178, and 193 min, while the DOC value at 193 min was 2.11 mg/L. These results indicate a significant reduction in organic carbon content as flocculation progressed, suggesting that chitosan promoted the formation of dense, settleable flocs with a high binding capacity for organic matter and the formation of compact and settleable flocs capable of capturing both particulate and dissolved organic fractions.
As shown in
Table 13, the TOC removal performance, flocculation process efficiency, and additional organic matter removal parameters were evaluated at different turbidity levels by using chitosan in lactic acid. The results demonstrated that the efficiency of the coagulation–flocculation process increased with turbidity, with higher turbidity waters requiring higher doses of chitosan and achieving greater removal of total organic carbon (TOC). Specifically, for the sample with 403 NTU, a final TOC concentration of 2.25 mg/L was achieved, corresponding to 38.7% removal. For the 1220 NTU sample, the final TOC was 2.12 mg/L (56.3% removal), and for the most turbid sample, 5038 NTU, TOC was reduced to 2.72 mg/L (66.0% removal). All these values exceeded those of the U.S. EPA enhanced coagulation requirements: 25% removal for TOC levels between 2 and 4 mg/L and 35% removal for TOC levels greater than 4 mg/L, assuming an alkalinity above 60 mg/L. This confirms that the treatment applied not only met but also surpassed the minimum regulatory targets across all conditions tested.
Additionally, the data revealed that the most significant TOC reduction occurred within the first 32 min of the process, after which the concentrations remained relatively stable or decreased only slightly. This trend indicates that chitosan acted most effectively during the coagulation and flocculation phases, where it facilitated the rapid aggregation and removal of organic matter. This performance is characteristic of chitosan’s high charge density and bridging capabilities, supporting its role as an efficient natural coagulant.
Further characterization of organic matter removal was carried out by calculating the dissolved organic carbon (DOC) and UV254 absorbance removal at 193 min. These parameters help to clarify the extent and nature of natural organic matter (NOM) removed. For the 403 NTU sample, 51.1% DOC removal and 49.1% reduction in UV254 were observed. For the 1220 NTU sample, the DOC and UV254 removal rates were 49.1% and 39.7%, respectively, whereas the 5038 NTU sample showed the highest removal: 64.3% DOC and 66.5% UV254. The substantial reduction in UV254 confirms the effective elimination of aromatic and humic substances, which are key precursors of disinfection byproducts (DBPs), whereas DOC removal reflects the reduction in hydrophilic organic fractions. Compared with the theoretical expectations based on the SUVA values, the experimental outcomes align well.
The 403 and 1220 NTU samples exhibited SUVA values in the 3.5–3.6 L·mg−1·m−1 range, suggesting intermediate aromaticity and expected TOC removals of 40–60%, while the 5038 NTU sample had a SUVA of 4.39, predicting 60–80% removal. The actual TOC removal values (38.7%, 56.3%, and 66.0%) were within or near the predicted ranges, confirming the suitability of the applied treatment. The flocculation efficiency was also high for all samples (94.6%, 98.2%, and 99.8%), further supporting the effectiveness of chitosan in particle removal under the tested conditions.
As presented in
Table 13, the coagulation–flocculation treatment using chitosan dissolved in lactic acid was effective in reducing THM formation potential (THMFP) across all turbidity ranges. Compared to the THMFP values of the raw water, a significant reduction was observed for each treated sample. For the 403 NTU sample, the raw water THMFP was 222 µg/L, which was reduced to 102 µg/L after treatment, a reduction of approximately 54.1%. In the case of 1220 NTU, THMFP decreased from 314 µg/L to 111 µg/L, resulting in a 64.6% reduction. The most notable change occurred in the 5038 NTU sample, where the raw THMFP concentration was 587 µg/L and dropped dramatically to 102 µg/L in the treated water, which is equivalent to a reduction of 82.6%. Although the TOC and DOC removal percentages in this set were slightly lower than those obtained with acetic acid (TOC removal of 38.7%, 56.3%, and 66.0% for increasing turbidity levels), the THMFP was better controlled, particularly for the sample with the highest turbidity. This suggests that lactic acid-based treatment was more effective at targeting specific fractions of NOM that are highly reactive in chlorine disinfection, especially those responsible for THM formation.
In terms of UV254, which serves as a proxy for aromatic organics, the removal was moderate, with final absorbance values of 0.056, 0.082, and 0.087 cm−1 for the 403, 1220, and 5038 NTU samples, respectively. These values indicate a reasonable reduction in the DBP precursors, particularly aromatic compounds. The residual chlorine levels in all the samples remained relatively high (0.95–1.21 mg/L), which ensured that disinfection was not limited by chlorine availability. Therefore, the lower THMFP values achieved with lactic acid likely stem from the more effective removal or alteration of highly reactive NOM components, not from reduced chlorination.
Figure 9 presents the comparative results of UV
254 absorbance, total organic carbon (TOC), and dissolved organic carbon (DOC) measured at 193 min for all turbidity levels evaluated in the jar test process. Overall, the results suggest that chitosan in lactic acid achieved strong THMFP control, especially at higher turbidity levels, despite achieving slightly lower TOC removal than the other acids. This highlights the importance of measuring both the organic matter concentration and reactivity when evaluating treatment effectiveness for DBP control.
3.4.4. Chitosan in L-Ascorbic Acid Solution at Different Raw Water Turbidity Ranges
In tests using raw water with an initial turbidity of 403 NTU, the first stage of jar testing with chitosan dissolved in L-ascorbic acid is presented in
Table 14, using a concentration range of 0.50 to 20.0 mg/L. A second, refined dose screening was conducted using concentrations between 2.00 and 12.0 mg/L to identify the most efficient coagulant dosage.
Table 14 also presents the results from this second stage, with turbidity measurements taken at 32 min of processing.
The optimum result was obtained with an 8.00 mg/L dose, corresponding to Jar 3, where final turbidity was reduced to 6.47 NTU at 193 min. The flocculation efficiency (EFP), calculated from the reduction between initial and post-treatment turbidity, reached 95.0% (from 403 to 20.1 NTU), confirming the success of this treatment setup.
TOC analyses for Jar 3 at the three time points yielded concentrations of [2.35, 2.28, 2.21] mg/L, and the DOC concentration at 193 min was 1.87 mg/L. These data suggest that chitosan in L-ascorbic acid exhibited a strong capacity for organic matter removal, supporting the formation of well-structured flocs throughout the process.
The jar test was conducted using raw water with an initial turbidity of 1220 NTU. The first stage of testing with chitosan dissolved in acetic acid is presented in
Table 15, using a concentration range of 3.00 to 30.0 mg/L. The second stage focused on a narrower dose range (6.00 to 15.0 mg/L) to determine the optimal coagulant dosage.
Table 15 also includes the results from this second stage, with turbidity measurements taken at 32 min of processing.
Among the tested doses, 13.00 mg/L (Jar 4) delivered the best results, achieving a turbidity of 7.52 NTU at the final stage. The efficiency of the flocculation process was assessed by comparing inlet and outlet turbidity values. The reduction from 1220 NTU to 17.9 NTU yielded an EFP of 98.5%, confirming the suitability of this dose under high turbidity conditions.
For the same setup, the TOC and DOC levels significantly decreased throughout the treatment. Measured TOC concentrations at 32, 178, and 193 min were [2.28, 1.99, 1.98] mg/L, while the DOC concentration was 1.56 mg/L at 193 min. These findings suggest that this coagulant formulation supported the generation of compact flocs with a high affinity for both particulate and dissolved organic matter.
In the case of raw water with extremely high turbidity (5038 NTU), the first stage of jar testing focused on a dose range of 10.0 to 50.0 mg/L to identify the optimal concentration.
Table 16 presents the results from this stage, with turbidity measured at 32 min of processing. The second stage involved testing chitosan dissolved in L-ascorbic acid across a narrower dose range (16.0 to 23.0 mg/L) to refine the determination of the most suitable treatment dosage.
Table 16 also includes the results from this second stage, with turbidity again analyzed at 32 min.
Chitosan in L-ascorbic acid was tested within a dose range of 16.00–23.00 mg/L to identify the most effective coagulant concentration. The dose of 21.00 mg/L (Jar 4) achieved the best performance, reaching a final turbidity of 2.51 NTU at the end of the process. Turbidity dropped from 5038 NTU to 4.84 NTU after flocculation, yielding a flocculation efficiency (EFP) of nearly 100%. These results validated the effectiveness of the dose in handling water with extremely high turbidity levels. The removal of organic carbon was also significant. At 32, 178, and 193 min, TOC values were [2.16, 2.12, 2.06] mg/L, while the DOC level at 193 min was 1.39 mg/L. This suggests that chitosan in L-ascorbic acid supported effective floc formation and consistent removal of both particulate and dissolved organics through the various treatment stages.
As presented in
Table 17, the TOC removal performance and flocculation efficiency were evaluated using chitosan in L-ascorbic acid at the three turbidity levels. The results showed a clear trend in which increased turbidity correlated with higher coagulant doses and enhanced organic matter removal. Most of the TOC reduction occurred within the first 32 min of treatment, suggesting that the chitosan–L-ascorbic acid formulation is particularly effective during the rapid coagulation–flocculation phase.
For the 403 NTU sample, an optimized dose of 8.00 mg/L resulted in a final TOC concentration of 2.21 mg/L, corresponding to a 39.8% TOC removal, which exceeds the 25% EPA minimum requirement for initial TOC levels between 2 and 4 mg/L. The DOC at the end of the process was 1.87 mg/L, indicating a 39.1% DOC reduction, and the UV4254 absorbance dropped by 39.1% (0.067 cm−1 at 193 min), highlighting effective removal of aromatic compounds. These values suggest moderate removal of hydrophobic fractions, consistent with the expectations for raw water with intermediate SUVA values.
For the 1220 NTU sample, a dose of 13.0 mg/L produced a final TOC of 1.98 mg/L from an estimated initial value of 4.85 mg/L, equating to a 59.2% TOC removal, again exceeding the 35% EPA requirement. The DOC decreased to 1.56 mg/L, representing a 58.6% DOC reduction, and the UV absorbance declined by 51.5%, suggesting the effective elimination of aromatic, humic-type organics. These outcomes align well with the theoretical SUVA-based TOC removal predictions in the 40–60% range for waters with intermediate aromatic contents. In the most turbid sample (5038 NTU), treated with 21.0 mg/L of chitosan–lactic acid, TOC was reduced to 2.06 mg/L, achieving a 74.3% removal, which is well above the 35% EPA target. The DOC was reduced to 1.39 mg/L (76.4% DOC removal), and UV4254 absorbance dropped by 70.8%, confirming a strong reduction in high-molecular-weight, aromatic organic matter typical of highly turbid river water dominated by humic substances. This performance is consistent with the theoretical SUVA removal range of 60–80% for waters with a high aromatic content. Across all turbidity levels, flocculation efficiency remained high, ranging from 95.0% to 99.9%, indicating excellent particle aggregation and sedimentation following the treatment. These findings reinforce the effectiveness of chitosan–L-ascorbic acid as a natural coagulant, particularly for water sources rich in humic substances and NOM with an aromatic character.
The effectiveness of chitosan dissolved in L-ascorbic acid in reducing trihalomethane formation potential (THMFP) was evaluated at three turbidity levels, as presented in
Table 17. The comparison between the THMFP of raw water and that of finished water (FW) demonstrated a significant reduction across all conditions tested.
At 403 NTU, the raw water had a THMFP of 222 µg/L, while the finished water showed 177 µg/L, corresponding to a 20.3% reduction. For the 1220 NTU condition, the THMFP decreased more markedly from 314 µg/L in the raw water to 102 µg/L in the treated sample, a 67.5% reduction. At the highest turbidity level (5038 NTU), THMFP decreased from 587 µg/L to 108 µg/L, achieving an impressive 81.6% reduction. These results suggest that L-ascorbic acid was highly effective at minimizing DBP precursors, particularly in waters with higher turbidity.
The final TOC removal percentages (39.8%, 59.2%, and 74.3%, respectively) aligned well with the observed THMFP reductions. For the most turbid sample, both TOC and DOC removal were the highest (TOC: 74.3%; DOC: 1.39 mg/L). The UV
254 absorbance values (ranging from 0.066 to 0.076) also indicate notable removal of aromatic organics, which are closely linked to THM formation. Additionally, the relatively low residual chlorine levels across all samples (0.54–0.84 mg/L) suggest that chlorine demand was adequately managed post-treatment.
Figure 10 presents the comparative results of UV
254 absorbance, total organic carbon (TOC), and dissolved organic carbon (DOC) measured at 193 min for all turbidity levels evaluated in the jar test process. Overall, these findings highlight the potential of l-ascorbic acid as a promising co-solvent for chitosan in water treatment, particularly for effectively reducing DBP precursors in high-turbidity scenarios.
3.4.5. Aluminum Chlorohydrate (GC 850) to Jar Test Analysis at Different Turbidity Ranges
The jar test concentrations for GC850 (aluminum chlorohydrate, ACH) were determined based on the dosage routinely applied at the municipal water treatment plant (MWTP) during the sampling period. As a result, no preliminary dose optimization tests were conducted for this coagulant, in contrast to the multi-stage jar testing approach employed for chitosan formulations.
In tests using raw water with 403 NTU turbidity, the jar test performance with GC850 (ACH) is presented in
Table 18. Jar 4, which achieved the lowest turbidity value of 0.89 NTU, was selected as the optimal dose and analyzed for UV
254 absorbance, total organic carbon (TOC), and dissolved organic carbon (DOC) at 193 min.
A coagulant dose of 12 mg/L, equivalent to the concentration applied at the municipal water treatment plant (MWTP) for that turbidity range, was used. In the full-scale process, the MWTP achieved a sedimentation turbidity of 3.22 NTU and a final filtered water turbidity of 0.23 NTU.
In tests using raw water with 1220 NTU turbidity with GC850 (ACH), the jar test performance is presented in
Table 19. Jar 4, which achieved the lowest turbidity value of 2.64 NTU, was selected as the optimal dose and analyzed for UV
254 absorbance, total organic carbon (TOC), and dissolved organic carbon (DOC) at 193 min. A coagulant dose of 16 mg/L, equivalent to the concentration applied at the municipal water treatment plant (MWTP) for that turbidity range, was used. In the full-scale process, the MWTP achieved a sedimentation turbidity of 4.01 NTU and a final filtered water turbidity of 0.18 NTU.
In tests using raw water with 5038 NTU turbidity with GC850 (ACH), the jar test performance is presented in
Table 20.
Jar 3, which achieved the lowest turbidity value of 3.25 NTU, was selected as the optimal dose and analyzed for UV254 absorbance, total organic carbon (TOC), and dissolved organic carbon (DOC) at 193 min. A coagulant dose of 19.0 mg/L, equivalent to the concentration applied at the municipal water treatment plant (MWTP) for that turbidity range, was used. In the full-scale process, the MWTP achieved a sedimentation turbidity of 4.31 NTU and a final filtered water turbidity of 0.22 NTU.
As presented in
Table 21, the TOC removal performance, flocculation efficiency, and disinfection byproduct precursor reduction were evaluated using GC850 (aluminum chlorohydrate) at three turbidity levels. Unlike the chitosan treatments, the dosage selection for GC850 was based on the operational dose applied at the municipal water treatment plant (MWTP) during the study period, without prior optimization through staged jar tests.
At 403 NTU, a dose of 12.0 mg/L reduced the TOC from 3.67 mg/L (raw water) to 2.01 mg/L at 193 min, achieving a 45.2% removal rate, which surpasses the U.S. EPA minimum requirement of 25% for water sources with initial TOC concentrations between 2 and 4 mg/L. The DOC concentration was lowered to 1.86 mg/L, and UV254 absorbance dropped significantly to 0.027 cm−1, indicating efficient removal of aromatic organic matter. The flocculation efficiency was 99.8%, and the THM formation potential (THMFP) decreased from 222 µg/L (raw water) to 105 µg/L, representing a 52.7% reduction. Residual chlorine measured 1.42 mg/L, suggesting an effective oxidation process with manageable chlorine demand.
For the 1220 NTU sample, 16.0 mg/L of GC850 reduced the TOC from 4.85 mg/L to 2.12 mg/L (43.7% removal), also exceeding the EPA target of 35% for this TOC range. DOC decreased to 1.91 mg/L, and UV254 absorbance reached a low of 0.015 cm−1. The THMFP dropped from 314 µg/L to 112 µg/L (64.3% reduction), and flocculation efficiency remained high at 99.8%. Residual chlorine was 0.79 mg/L.
In the most turbid sample (5038 NTU), 19.0 mg/L of GC850 reduced TOC from 8.00 mg/L to 2.02 mg/L, achieving a 74.8% removal—well above the 35% EPA minimum. DOC was reduced to 1.75 mg/L, and UV254 absorbance dropped to 0.016 cm
−1. These reductions reflect effective removal of humic, hydrophobic NOM fractions commonly associated with high SUVA values and turbidity. THMFP was reduced from 587 µg/L (raw water) to 105 µg/L (82.1% reduction), confirming significant removal of DBP precursors. Residual chlorine remained within a controlled range at 1.86 mg/L, with flocculation efficiency reaching 99.9%.
Figure 11 presents the comparative results of UV
254 absorbance, total organic carbon (TOC), and dissolved organic carbon (DOC) measured at 193 min for all turbidity levels evaluated in the jar test process.
Figure 12 presents a comparison between chitosan and ACH regarding both flocculation efficiency and THMFP across all tested turbidity levels.
Figure 13 shows total organic carbon (TOC) removal during jar testing using chitosan dissolved in different acidic solutions and the conventional coagulant ACH, evaluated across all turbidity ranges. Overall, GC850 demonstrated strong coagulation performance and substantial removal of TOC and THM precursors, particularly under high-turbidity conditions. However, the relatively high residual chlorine levels observed may warrant further consideration for post-treatment optimization.
3.5. Comparative Analysis of Chitosan Acidic Solutions and Conventional Coagulant Performance, Including the Literature
Each acid used (acetic, lactic, and L-ascorbic) affects the solubility, reactivity, and stability of chitosan in solution differently.
Figure 11 and
Figure 12 present a consolidated comparison of the performance of chitosan dissolved in three organic acids (acetic, lactic, and L-ascorbic) versus the conventional coagulant GC850 (ACH), across three turbidity levels (403, 1220, and 5038 NTU). As shown in
Figure 13, TOC removal improved with increasing turbidity for all treatments. Chitosan in L-ascorbic acid achieved the highest removal at high turbidity (74.3% at 5038 NTU), closely matching GC850 (74.8%). At low turbidity (403 NTU), chitosan in acetic acid showed removal rates closest to GC850. All chitosan-based treatments met or exceeded the EPA’s minimum TOC removal requirement (25%) for low-alkalinity waters, aligning with theoretical expectations based on SUVA values.
Final TOC values at 193 min (
Table 17) confirmed that chitosan in L-ascorbic acid and GC850 (
Table 21) achieved the lowest residual TOC across all turbidity conditions, indicating effective organic matter reduction. Chitosan in acetic acid also performed well, particularly at moderate to high turbidity.
Final UV
254 absorbance values (
Figure 11) indicate significant reductions in aromatic and hydrophobic compounds. GC850 achieved the lowest UV
254 values, followed closely by chitosan in acetic and L-ascorbic acids, especially at high turbidity. This suggests effective removal of aromatic natural organic matter, which is crucial for limiting disinfection byproduct (DBP) formation.
DOC removal varied by acid type and turbidity level. Chitosan in acetic acid performed best at medium turbidity, while GC850 showed consistent results across all conditions. At high turbidity, L-ascorbic acid matched the DOC reduction of GC850. At 5038 NTU, acetic acid achieved the highest DOC (78.5%) and UV
254 (76.2%) removal, likely due to excellent dispersion and exposure of active sites. Its low viscosity enhances polymer mobility, promoting stable and cohesive floc formation [
23,
24]. Additionally, its simple carboxylic structure facilitates effective protonation of chitosan amino groups, improving solubility. In contrast, lactic acid exhibited higher viscosity, which may hinder chitosan dispersion and reduce charge neutralization efficiency [
25]. Despite this, it achieved acceptable removals (TOC: 66%, UV
254: 66.5%), potentially supported by its α-hydroxy acid structure, which fosters intermolecular interactions that increase viscosity and affect flocculation dynamics.
L-ascorbic acid, a strong and reducing acid, demonstrated high TOC (74.3%) and THMFP (81.6%) removal despite slightly lower DOC performance. This may be due to its ability to interact with aromatic precursors and modify the structure of some organics, making them more accessible for coagulation. Its multiple hydroxyl groups may also influence chitosan solubility and solution stability [
26].
Figure 12b shows that THMFP was lowest for GC850 and chitosan in lactic acid, indicating effective DBP precursor removal. While L-ascorbic acid yielded high TOC removal, its higher THMFP may result from residual organics remaining reactive with chlorine.
Figure 12a confirms that all treatments achieved flocculation efficiencies above 94%. At high turbidity, both chitosan in L-ascorbic acid and GC850 reached or exceeded 99.9%, demonstrating that properly formulated chitosan can rival conventional coagulants in clarification processes.
The observed variation in TOC, DOC, and UV254 removal across turbidity levels can be attributed, in part, to differences in the nature and concentration of natural organic matter (NOM) present in the raw water. At lower turbidity levels (403 and 1220 NTU), SUVA values (~3.6 L·mg−1·m−1) suggest intermediate aromaticity and a mixture of humic and non-humic substances, including hydrophilic components. This type of NOM is typically more challenging to remove, especially the non-humic, low-molecular-weight fractions, which are less prone to coagulation. As a result, TOC and DOC removal at these turbidity levels was moderate, and performance differences between acids became more evident due to their impact on chitosan’s solubility and interaction with specific NOM fractions. In contrast, at 5038 NTU, the NOM profile shifted notably. A higher SUVA value of 4.39 L·mg−1·m−1 indicates dominance of aromatic, humic, and hydrophobic compounds, which are more amenable to removal by coagulation and flocculation processes due to their larger molecular size and higher reactivity. This aligns with the observed increase in TOC and UV254 removal across all treatments at this turbidity level. Both GC850 and chitosan in L-ascorbic acid achieved TOC removals exceeding 74%, while UV254 absorbance was also significantly reduced, reflecting effective removal of aromatic DBP precursors.
This behavior is consistent with theoretical TOC removal estimates and EPA guidelines, further validating the applicability of chitosan in treating waters with varying organic loads. Previous studies have addressed different aspects of chitosan’s performance. Ampai Soros et al. concluded that chitosan has the potential to serve as an effective alternative coagulant for turbidity removal in water, demonstrating its applicability under moderate turbidity conditions [
27].
Tomoko Takaara investigated the use chitosan as a coagulant aid. The study found that chitosan could replace polyacrylamide, contributing to improved treated water safety by reducing potential health risks [
10].
R. Fabris et al. reported that chitosan was highly effective for particle removal at doses significantly lower than those required by conventional inorganic coagulants. However, chitosan alone was not particularly effective for dissolved organic carbon (DOC) removal, especially when used as the sole treatment step. When applied as the final clarification stage of a multi-step process, it showed limited turbidity reduction, likely due to specific flocculation requirements [
28].
Furthermore, Eleanor B. Holmes et al. evaluated chitosan as a coagulation–flocculation pretreatment to enhance the performance of intermittently operated slow sand filtration systems. They reported reductions in bacteria, viruses, and turbidity when water was pre-treated with 10 mg/L of chitosan followed by flocculation [
29].
Building upon this prior work, the present study demonstrates the effectiveness of chitosan as a primary coagulant under significantly higher turbidity conditions (up to 5038 NTU), while also evaluating the removal of TOC, DOC, and UV254. This provides a broader and more comprehensive assessment of chitosan’s performance, especially in challenging raw water matrices, and highlights its potential as a sustainable coagulant for improving treated water quality and reducing health risks.
Overall, the results support the use of chitosan—especially when formulated with L-ascorbic or acetic acid—as a viable natural coagulant, capable of matching or approaching the performance of conventional coagulants across multiple treatment metrics. UV254 reduction indicates the effective removal of aromatic DBP precursors, reinforcing the environmental relevance of these treatments.
3.6. Translating Laboratory Results to Real-World Applications in Water Treatment
3.6.1. Limitations of Jar Tests and Potential for Real-Scale Implementation
Jar test experiments, while essential for optimizing coagulant doses and understanding coagulation–flocculation mechanisms under controlled conditions, present certain limitations. These include the use of fixed mixing speeds, ideal settling conditions, and small volumes that do not reflect the hydraulic dynamics, flow variations, and chemical interferences present in full-scale treatment plants. Consequently, performance metrics such as TOC or DOC removal may vary when scaled up, and operational challenges such as sludge handling or coagulant mixing efficiency cannot be fully assessed through bench-scale testing alone. Nevertheless, despite these known limitations, jar testing remains an approved and widely accepted method by regulatory agencies for process control in water treatment facilities, as it provides a reliable indication of how a specific coagulant dose may perform under actual plant conditions.
To assess the practical value of chitosan as a coagulant, real-scale or pilot-scale studies are necessary. These can explore two key application strategies: (1) using chitosan as a primary coagulant, especially in high-turbidity, NOM-rich waters, and (2) applying chitosan as a coagulant aid alongside traditional agents such as aluminum sulfate or ferric chloride. The latter approach has shown promise in reducing required doses of conventional chemicals, improving floc formation, and lowering chlorine demand, thereby helping meet DBP regulations. Real-scale evaluations would also allow for assessing sludge characteristics, operational costs, and long-term sustainability.
3.6.2. Factors Influencing Chitosan Coagulation Performance in Water Treatment
The results obtained in this study demonstrate that the efficiency of chitosan as a natural coagulant varies significantly depending on the acid solvent used and the turbidity level of the raw water. This variation can be explained by a combination of physicochemical factors related to the nature of chitosan, the composition of the natural organic matter (NOM) present in the water, and the influence of the acidic medium on the structure and charge of the polymer.
The chitosan used, with a degree of deacetylation of 75% and a molecular weight of 460 kDa, contains amino groups (-NH2) that, when protonated in an acidic medium, acquire a positive charge (-NH3+). This allows electrostatic interactions with anionic organic compounds, such as humic and fulvic acids, which are commonly found in NOM.
The SUVA values obtained for the raw water (>3.5 L/mg·m) indicate a predominance of humic substances with high aromaticity and hydrophobicity. These characteristics enhance removal by flocculation and adsorption onto cationic polymers. This chemical affinity becomes particularly significant under high-turbidity conditions, where the elevated concentration of suspended particles and aromatic compounds provides additional sites for interaction. The selection of acetic acid, lactic acid, and L-ascorbic acid as solvents for chitosan dissolution was driven by key considerations related to their chemical characteristics, environmental relevance, and practical suitability for drinking water applications. These organic acids are naturally occurring in aquatic and terrestrial ecosystems and are commonly produced through microbial or plant metabolic activity, which aligns with the sustainability goals of this study [
30,
31,
32].
Additionally, their biodegradable nature minimizes environmental risks when compared to inorganic acids, such as hydrochloric or sulfuric acid, which may introduce corrosion or toxic byproducts into the treated water [
33]. Importantly, these acids also provide the necessary protonation environment (pH ~3.5–4.5) for dissolving chitosan. Due to their pKa values, acetic acid (~4.76), lactic acid (~3.86), and L-ascorbic acid (~4.2) are suitable for efficient amino group protonation on the chitosan polymer chain [
34,
35,
36]. Their history of safe use in the food and pharmaceutical industries further supports their feasibility for drinking water applications. Both acetic and lactic acid are classified as GRAS (Generally Recognized As Safe) by regulatory agencies, and L-ascorbic acid is an essential vitamin, which collectively reduces concerns about toxicity [
37].
This combination of natural origin, low environmental impact, suitable chemical reactivity, and regulatory acceptance underscores the relevance of these acids as effective and sustainable solvents for chitosan-based water treatment systems.
The removal efficiency of TOC, UV254, and THMFP increased notably with turbidity levels. At 403 NTU, removal rates were modest (TOC 35–40%, UV254 < 50%, THMFP 20–53%), which is consistent with a lower concentration of organic matter and less reactive NOM. At 1220 NTU, a significant increase was observed across all parameters, highlighting the impact of higher colloidal load and greater aromatic content. At 5038 NTU, the best results were achieved: the high concentration of NOM, its humified nature (SUVA of 4.39), and greater contact potential between chitosan and THM precursors enabled removal efficiencies exceeding 70% for all indicators.
These results confirm that chitosan is particularly effective in scenarios where the water is heavily loaded with aromatic NOM and suspended particles. Under such conditions, coagulation is enhanced through charge neutralization, interparticle bridging, and selective adsorption mechanisms.
The choice of acid solvent has a significant impact on the performance of chitosan as a coagulant, modulating its colloidal behavior, adsorption capacity, and affinity for organic substances. Acetic acid appears to offer the best combination of efficiency and stability, closely followed by L-ascorbic acid. Turbidity acts as an enhancing factor in the coagulation process by increasing the availability of interaction sites and the amount of organic matter to be removed.
The practical application of chitosan as a coagulant in water treatment processes is supported not only by its demonstrated effectiveness in TOC, DOC, and UV
254 removal at varying turbidity levels but also by its economic feasibility. Based on dosing ranges observed in this study (2.00–21.0 mg/L depending on turbidity), an estimated 2–3 kg of chitosan powder would be required per 1,000,000 liters of treated water. The bulk market price of technical-grade chitosan typically ranges from 10 to 20 USD/kg, resulting in a treatment cost of approximately USD 20–60 per million litters. When compared with traditional coagulants such as aluminum sulfate, which can cost upwards of USD 140 per million liters (at typical dosages), chitosan presents a competitive alternative [
38].
Additionally, chitosan offers environmental and health benefits as a biodegradable, non-toxic polymer derived from renewable sources, mainly crustacean shells. While it is not yet standardized as a disinfectant by regulatory agencies like the EPA, its safety profile is well established, and its use in water treatment is supported by multiple studies. Challenges related to storage conditions and stability during large-scale processing remain areas for further research; however, the current evidence suggests chitosan’s strong potential as a sustainable and cost-effective coagulant in water purification systems.
3.6.3. Recommendations for Water Treatment Facilities
Chitosan powder must be stored under specific environmental conditions to preserve its physicochemical integrity and coagulant efficiency. Temperature is a critical factor; chitosan should be kept in a cool environment, ideally between 2 °C and 8 °C, as exposure to temperatures above 40 °C may lead to moisture loss and polymer degradation, which negatively affects its mechanical strength and functional properties [
39]. Additionally, because chitosan is a hygroscopic material, it readily absorbs moisture from the surrounding air. When relative humidity exceeds 60%, its water content can increase significantly, promoting swelling, plasticization, and hydrolytic degradation [
39,
40]. Therefore, proper packaging is essential. Chitosan should be stored in hermetically sealed, opaque containers made of materials that can protect it from light and moisture while maintaining stable internal conditions [
41].
It is important to note that storage requirements may vary depending on the physical state and formulation of the chitosan product. While the conditions apply to the dry powder form, chitosan solutions or industrially prepared blends—particularly those formulated with specific acids or coagulant aids—may have distinct handling and preservation needs. In such cases, storage conditions should be aligned with the manufacturer’s specifications, including recommendations related to pH stability, temperature sensitivity, and shelf life. Ensuring proper storage tailored to the product’s formulation is essential to maintaining its coagulation performance and chemical stability over time.
Chitosan’s hygroscopic nature—its tendency to absorb moisture from the environment—can negatively impact its flowability and dosing accuracy. Improper storage conditions may lead to clumping, which hinders uniform application and reduces its performance as a coagulant [
40]. Additionally, extended exposure to high humidity and elevated temperatures accelerates the hydrolysis of chitosan, resulting in a reduction of its molecular weight. This degradation compromises its structural integrity and diminishes its effectiveness in water treatment applications [
39].
To ensure optimal performance and longevity of chitosan during storage and use, several best practices should be implemented. Inventory control is essential and should follow a first-in, first-out (FIFO) protocol to ensure that older stock is used first and within its effective shelf life. Environmental monitoring systems must be installed in storage areas to maintain appropriate humidity and temperature levels, thereby preventing premature degradation. It is also important to train operational personnel in proper handling and storage procedures to minimize the risk of contamination and physicochemical deterioration. Finally, periodic quality checks—such as assessing the physical appearance, flowability, and pH of chitosan in solution—should be routinely conducted to verify that the stored material remains suitable for use prior to application.
Meeting the growing regulatory pressures surrounding disinfection byproducts (DBPs), many of which are classified as potentially carcinogenic, remains a major challenge for water utilities. Although adopting biopolymer-based coagulants like chitosan may require additional investment in material procurement and storage infrastructure, these initial costs are offset by long-term benefits. These include reduced DBP formation, improved environmental sustainability, and enhanced protection of public health. From both municipal and private-sector perspectives, such benefits are not merely advantageous, but essential in developing resilient and future-oriented water treatment strategies.